Back to search

South Dakota State University

Exploration of Host Health Benefits by a Defined Consortium of Butyrate-Producing Human Gut Bacteria In Gnotobiotic Mouse Model

Abstract

dc:description.abstract

Aberrant gut microbiota composition is found to be associated with several human diseases such as inflammatory bowel diseases (IBD). Reduction in butyrate producing bacteria is one of the characteristic features of such dysbiotic bacterial community in the gut. Modulation of gut microbiota to bring the dysbiotic state back to normal healthy state is a promising therapeutic strategy to cure several diseases like recurrent Clostridium difficile infection (rCDI) and IBD where traditional therapies using pharmacological substances fails to make a difference. Restoration of butyrate producers is found to be an effective method of such gut microbiota modulation. The potential to produce butyrate is phylogenetically diverse and not even present in all members of the same family. Hence the number of identified bacteria that can produce butyrate is not vast and most of them were not explored for their functional roles towards host health benefits. Low abundance and the difficulty to culture these strictly anaerobic organisms are the few reasons of their under exploration. Here we examine the immunomodulatory properties of four butyrate producing human gut bacterial species as a defined mix using gnotobiotic mouse as a model. Our study shows, these allochthonous bacterial strains assemble in the germ-free mouse gut and produce butyrate as one of the short chain fatty acids. Without causing any pathological changes, successful colonization of these bacteria fortifies the innate immune defense system by enhancing the expression of regenerating islet-derived protein 3 beta (Reg3b), regenerating islet-derived protein 3 gamma (Reg3g), mucin 2 (Muc2) and defensin beta (Defb) genes in the colon and modulating the adaptive immune cell populations at the systemic levels. However, precolonization of these bacteria did not show any significant changes in pro and antiinflammatory responses in gnotobiotic mice compared to germ free mice under colitis induced by Dextran sulfate sodium (DSS). But a better gross and histopathological appearance of colon in gnotobiotic mice indicates that these bacteria have some role in attenuating colitis rather aggravating it and thus can be considered as candidates of bacterial therapeutics.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy (PhD)
Level thesis:degree_level
Thesis - Open Access
Discipline thesis:degree_discipline
Veterinary and Biomedical Sciences

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Antony, Linto
Contributors dc:contributor
  • Joy Scaria

Subjects

dc:subject × 1

Rights

dc:rights

Identifiers

dc:identifier.*
Repository record dc:identifier
https://openprairie.sdstate.edu/etd/5277

Chain of custody

source
Harvested from
South Dakota State University
Base URL
openprairie.sdstate.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Antony, Linto. Exploration of Host Health Benefits by a Defined Consortium of Butyrate-Producing Human Gut Bacteria In Gnotobiotic Mouse Model. Thesis - Open Access thesis, https://openprairie.sdstate.edu/etd/5277